FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental NDA for phentermine/topiramate from Prasco Laboratories. This action updates the labeling for the combination obesity treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Phentermine and topiramate (Phentermine and topiramate)

Snippet

SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)